TRANSCRIPT
The Operator: Good evening. The tape is quiet tonight, which means we listen closer to the noise. According to CNBC Technology, a San Francisco federal judge has ruled that the Department of Defense violated the First Amendment by designating AI company Anthropic a supply chain risk in retaliation for its criticism of government views.
The Operator: The ruling bars defense contractors from using Anthropic's technology based on that designation, though litigation in D.C. remains ongoing. Meanwhile, the financial landscape shifts further west. According to CNBC Technology, Sheikh Tahnoon bin Zayed al Nahyan and his co-investors now own a 49% stake in WLTC Holdings, the holding company for World Liberty Financial's planned federally chartered bank.
The Operator: This follows a previous $500 million investment by Tahnoon into World Liberty Financial, which directed $263 million to Trump family entities. Turning to the markets, according to CNBC Earnings, CrowdStrike and Okta shares surged on AI-driven cybersecurity demand.
The Operator: The stocks rose 20% and nearly 29% respectively after beating fiscal Q2 earnings estimates and raising guidance due to increased spending on AI threat defense. The broader cyber sector rallied, with Palo Alto Networks, SailPoint, Zscaler, and Rubrik gaining at least 10% as companies scale security stacks against AI-agency attacks.
The Operator: Okta topped fiscal some number estimates with adjusted earnings per share of $1.05 and revenue of $805 million, driven by new products accounting for 30% of total bookings. The company closed its acquisition of threat detection startup Permiso Security for roughly $200 million and raised its full-year revenue guidance to between $3.22 billion and $3.23 billion.
The Operator: In other health sector news, according to Yahoo Finance, Spyre Therapeutics stock plunged after its experimental treatment for rheumatoid arthritis failed to meet expectations in midstage testing. Despite this setback, analysts remain focused on the company's inflammatory bowel disease pipeline, maintaining a price target of approximately $115.
The Operator: Numbers don't care how loud you type them. We'll see you tomorrow.
The Operator: That's the show. We're on Spotify and YouTube — if this earned it: like, subscribe, tell a friend. And housekeeping: the machine that writes this gets tuned constantly for cleaner news. The numbers are real; the jokes are not. One more thing: this whole station runs on one garage computer, and if the tape ever earned you a coffee, there's a tip jar at informant.reiners.io. It keeps the phone line on.